(内分泌系统）Nuclear Medicine in Endocrine System知识介绍.pptVIP

Nuclear Medicine in Endocrine System;核医学（Nuclear Medicine);;*;Content;放射性药物Radiopharmaceuticals ;The indications for scintigraphic thyroid imaging;Normal imaging;Ectopic Thyroid Tissue. ;Substernal thyroid ;Thyroid Nodules ; 冷/凉结节 Cold or cool nodule;;;Discordant Thyroid Nodule ;Diffuse Toxic Goiter (Graves Disease) ;Multinodular Gland ;;Subacute granulomatous thyroiditis;Subacute thyroiditis; Assessment thyroid remnant;Congenital Organification Defect ;RAIU is based on the principle that the administered radiopharmaceutical is concentrated by the thyroid gland in a manner that reflects the gland’s handling of stable dietary iodine and therefore the functional status of the gland. ;To differentiate Graves disease from subacute thyroiditis or factitious hyperthyroidism. To determine how much activity to administer as a treatment dose for hyperthyroidism radioiodine therapy.; RAIU Technique ;Formula ;;RAIU ;Factors Affecting Iodine Uptake;Parathyroid imaging and localization ; PTH;parathyroid adenomas location;Imaging parathyroid adenomas;Normal parathyroid scan;Parathyroid adenoma;Localization by SPECT/CT;;Radioiodine Therapy ; 131I treatment of hyperthyroidism ;甲状腺功能亢进症（Hyperthyroidism） ;病因?（Etiologies）;;;;;甲状腺相关性眼病 (Thyroid related opthalmopathy);胫前粘液性水肿 (Pretibial Myxedema);Choice of Treatment;内科：疗效肯定、很少引起永久性甲低 疗程长、易复发、过敏反应、骨髓抑制、肝功能损害 手术：疗效确切，起效快，复发率低 永久性甲低，并发症，手术瘢痕 131I： 疗效确切、简便安全、复发率低，并发症少、费用低 永久性甲低 诱发或加重突眼 ;Treatment Choice Decision;131I治疗甲亢的原理;交叉火力效应Cross-fire effect;131I治疗后甲状腺组织变化;Radiation Absorbed Dose from 131I ;131I Treatment;;;适应证 Indications;禁忌证 Contraindications;;计算公式 Calculation Formula;剂量调整因素Dose Consideration;病人准备Patient preparation;Radiation safety after treatment with 131I;Results of Therapy;Short-term effects of RAI;Long-term effects of RAI;现实目标： 治愈甲亢，而不是避免甲减的发生。 The goal should be cure of hyperthyroid rather than avoidance of hypothyroid. ?;;;;;分化型甲状腺癌（Differenti